ENDOCRINE PHARMACEUTICALS LIMITED

Total exemption full accounts made up to 30 Jun 2026

PDF · 8 pages

Confirmation statement made on 15 Mar 2026 with no updates

PDF · 3 pages

Total exemption full accounts made up to 30 Jun 2025

PDF · 8 pages

Confirmation statement made on 15 Mar 2025 with updates

PDF · 15 pages

Statement of capital following an allotment of shares on 15 Feb 2025

PDF · 3 pages

Total exemption full accounts made up to 30 Jun 2024

PDF · 8 pages

Confirmation statement made on 15 Mar 2024 with updates

PDF · 16 pages

Statement of capital following an allotment of shares on 19 Feb 2024

PDF · 3 pages

Total exemption full accounts made up to 30 Jun 2023

PDF · 8 pages

Confirmation statement made on 4 Jan 2023 with updates

PDF · 17 pages

Statement of capital following an allotment of shares on 5 Jan 2022

PDF · 3 pages

Statement of capital following an allotment of shares on 27 Apr 2022

Filed on paper · 4 pages

Statement of capital following an allotment of shares on 15 Jun 2021

Filed on paper · 4 pages

Total exemption full accounts made up to 30 Jun 2022

PDF · 8 pages

Total exemption full accounts made up to 30 Jun 2021

PDF · 8 pages

Confirmation statement made on 4 Jan 2021 with no updates

PDF · 3 pages

Total exemption full accounts made up to 30 Jun 2020

PDF · 8 pages

Appointment of Mr Gavin Fairlie Douglas as a director on 30 Jun 2020

PDF · 2 pages

Termination of appointment of Timothy Graham Walker as a director on 30 Jun 2020

PDF · 1 page